Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Anti-angiogenesis
100%
Tumor
66%
Antiangiogenic
66%
Vascular Permeability
66%
Programmed Death-ligand 1 (PD-L1)
66%
Vascular Endothelial Growth Factor Receptor (VEGFR)
33%
Cancer Patients
33%
Blood Flow
33%
Chemotherapy
33%
Vascular Supply
33%
Immunosuppression
33%
Overexpression
33%
Vasculature
33%
Angiogenesis
33%
Overall Survival
33%
Mechanistic Understanding
33%
Cancer Treatment
33%
Hypoxia
33%
Angiogenic Factors
33%
Tumor Vasculature
33%
Blood Oxygenation
33%
Targeted Therapy
33%
Synergize
33%
Tumor Vessels
33%
Advanced Cancer
33%
Antiangiogenic Therapy
33%
Tumor Cell Proliferation
33%
New Blood Vessel
33%
Durable Response
33%
Anti-VEGF Therapy
33%
Pharmacological Agents
33%
Tumor Perfusion
33%
Tumor Cell Viability
33%
Blood Perfusion
33%
Perfusion Flow
33%
High Interstitial
33%
Interstitial Fluid Pressure
33%
Combination Immunotherapy
33%
Immune Checkpoint
33%
Immune Checkpoint Blockers
33%
Death Receptor Ligand
33%
Medicine and Dentistry
Malignant Neoplasm
100%
Immunotherapy
100%
Antiangiogenic Activity
100%
Neoplasm
75%
Vasculotropin
50%
Antiangiogenic
50%
Blood Vessel Permeability
50%
Blood Flow
25%
Cell Viability
25%
Cell Proliferation
25%
Tumor Cell
25%
Immunosuppressive Treatment
25%
Vascularity
25%
Angiogenesis
25%
Overall Survival
25%
Cancer Therapy
25%
Hypoxia
25%
Targeted Therapy
25%
Advanced Cancer
25%
Vascular Bundle
25%
Angiogenic Factor
25%
Tumor Vascularization
25%
Programmed Death-Ligand 1
25%
Death Receptor
25%
Antiangiogenic Therapy
25%
Interstitial Fluid
25%
Tumor
25%
Biochemistry, Genetics and Molecular Biology
Antiangiogenic Activity
100%
Vascular Endothelial Growth Factor
66%
Perfusion
66%
Blood Vessel Permeability
66%
Immune Checkpoints
66%
Cell Proliferation
33%
Blood Flow
33%
Angiogenesis
33%
Cell Viability
33%
Oxygenation
33%
Overall Survival
33%
Tumor Vascularization
33%
Vascularization
33%
PD-L1
33%
Tissue Pressure
33%
Targeted Therapy
33%
Immunology and Microbiology
Immunotherapy
100%
Antiangiogenic Activity
100%
Perfusion
50%
Vasculotropin
50%
Blood Vessel Permeability
50%
Blood Flow
25%
Immunosuppression
25%
Cell Proliferation
25%
Tumor Cell
25%
Cell Viability
25%
Blood Vessel
25%
Tumor Vascularization
25%
Vascularization
25%
Angiogenesis
25%
Overall Survival
25%
Angiogenic Factor
25%
Programmed Death-Ligand 1
25%
Oxygenation
25%
Tissue Pressure
25%
Death Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
100%
Immunotherapy
100%
Antiangiogenic
75%
Vasculotropin
50%
Chemotherapy
25%
Death Receptor
25%
Overall Survival
25%
Advanced Cancer
25%
Angiogenic Factor
25%
Tumor Vascularization
25%
Hypoxia
25%